CN102940845A - Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition - Google Patents
Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition Download PDFInfo
- Publication number
- CN102940845A CN102940845A CN2012105241236A CN201210524123A CN102940845A CN 102940845 A CN102940845 A CN 102940845A CN 2012105241236 A CN2012105241236 A CN 2012105241236A CN 201210524123 A CN201210524123 A CN 201210524123A CN 102940845 A CN102940845 A CN 102940845A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- chinese medicine
- medicine composition
- gastritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention provides a traditional Chinese medicine composition for treating gastritis. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 5-15 parts of pinellia, 10-20 parts of elecampane, 15-25 parts of loosestrife, 15-25 parts of forsythia, 10-20 parts of amomum cardamomum, 10-20 parts of rhizoma corydalis, 10-20 parts of toosendan fruit, 10-20 parts of herba hyperici japonica, 15-25 parts of coptis, 15-25 parts of tuckahoe, 15-25 parts of radix bupleuri, 5-10 parts of bighead atractylodes rhizome, 15-25 parts of fructus aurantii, 10-20 parts of cortex magnoliae officinalis, 15-25 parts of fiveleaf akebia fruit, 10-20 parts of areca, 15-25 parts of angelica, 10-20 parts of gizzard pepsin, 15-25 parts of concha arcae and 15-25 parts of liquorice. The traditional Chinese medicine composition has the functions of resolving damp with aromatics, regulating qi and invigorating stomach so as to treat the gastritis. The invention further discloses a preparation method and an application.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition that is used for the treatment of gastritis and its preparation method and application.
Background technology
Chronic atrophic gastritis refers to that the chronic gastritis that atrophic changes has occured gastric mucosa in the gastritis, and chronic atrophic gastritis can be divided into again many kitchen ranges atrophic gastritis and autoimmunity gastritis two large classes.Chronic atrophic gastritis is common disease of stomach.The hobby of arteriosclerosis, stomach Insufficience of blood flow, cigarette,wine and tea etc. all easily damage the barrier function of gastric mucosa and cause chronic atrophic gastritis.During chronic atrophic gastritis, gastric mucosa atrophy and to be replaced by the epithelial cell of intestinal be that intestinalization is given birth to; Inflammation continue to develop, and then Growth of Cells is not true to type, and becomes between namely; Even hyperplasia and carcinogenesis.The chronic atrophic gastritis clinical manifestation only the indigestion symptom such as moves back for Abdeminal pain, belch, stomach poor appetite, is sometimes destroyed because of gastric anti-pernicious anemia factor, and vitamin B12 malabsorption can cause anemia.Endoscopy and biopsy are the only resources of making a definite diagnosis chronic atrophic gastritis.Gastroscope Diagnosis should comprise that diseased region, atrophy degree, intestinalization are given birth to and the degree of atypical hyperplasia.The mucosa that naked eyes are line-of-sighted observation chronic atrophic gastritis is pale or greyish white more, and pleat attenuates or be smooth.The mucosa that mucosa can show Chronic Atrophic Gastritis Patients red and white, serious is dispersed in white speckle.Exposed vessel is the feature of chronic atrophic gastritis under the mucosa, can see red netted small artery or blood capillary, and as seen serious chronic atrophic gastritis has epithelial hyperplasia to form fine particle or than greater tubercle.Mucosal erosion is also arranged, bleeding.Mucosa Biopsy pathology is mainly in various degree atrophy of body of gland, disappearance, replaces gland metaplasia or intestinal gland metaplasia, and a matter inflammatory infiltration is remarkable.Chronic atrophic gastritis namely is positioned at the body of gland of gastric mucosa because of reasons such as inflammatory infiltrations, body of gland atrophy or disappearance.Its sickness rate of chronic atrophic gastritis is showed increased with the increase at age.Main manifestations is that epigastrium is glutted, discomfort or pain, and is obvious after the meal, simultaneously with other indigestion symptoms such as belch, acid regurgitation, feel sick, vomiting, inappetence etc.People are in the urgent need to a kind of effective, own Chinese medicine composition that can be played the treatment chronic atrophic gastritis of good result by the most people confirmation.
Summary of the invention
Goal of the invention: in order to address the above problem, the object of the present invention is to provide a kind of Chinese medicine composition that is used for the treatment of gastritis and its preparation method and application.
Technical scheme: the objective of the invention is to realize by following scheme:
A kind of Chinese medicine composition that is used for the treatment of gastritis, it is prepared by the raw material of following parts by weight: Rhizoma Pinelliae 5-15 part, Radix Aucklandiae 10-20 part, Herba Lysimachiae 15-25 part, Fructus Forsythiae 15-25 part, Fructus Amomi Rotundus 10-20 part, Rhizoma Corydalis 10-20 part, Fructus Toosendan 10-20 part, Herba Hyperici Japonici 10-20 part, Rhizoma Coptidis 15-25 part, Poria 15-25 part, Radix Bupleuri 15-25 part, Rhizoma Atractylodis Macrocephalae 5-10 part, Fructus Aurantii 15-25 part, Cortex Magnoliae Officinalis 10-20 part, Fructus Akebiae 15-25 part, Semen Arecae 10-20 part, Radix Angelicae Sinensis 15-25 part, Endothelium Corneum Gigeriae Galli 10-20 part, Concha Arcae 15-25 part, Radix Glycyrrhizae 15-25 part.
The above-mentioned Chinese medicine composition that is used for the treatment of gastritis, it is prepared by the raw material of following parts by weight: 10 parts of the Rhizoma Pinelliaes, 15 parts of the Radix Aucklandiae, 20 parts of Herba Lysimachiaes, 20 parts of Fructus Forsythiaes, 15 parts of Fructus Amomi Rotunduss, 15 parts of Rhizoma Corydalis, 15 parts of Fructus Toosendans, 15 parts of Herba Hyperici Japonici, 20 parts of Rhizoma Coptidis, 20 parts in Poria, 20 parts of Radix Bupleuri, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Fructus Aurantiis, 15 parts of Cortex Magnoliae Officinalis, 20 parts of Fructus Akebiaes, 15 parts of Semen Arecaes, 20 parts of Radix Angelicae Sinensis, 15 parts of Endothelium Corneum Gigeriae Galli, 20 parts of Concha Arcaes, 20 parts in Radix Glycyrrhizae.
The above-mentioned Chinese medicine composition that is used for the treatment of gastritis, described raw material add adjuvant and make oral liquid, tablet, capsule or granule after extracting.
The above-mentioned Chinese medicine composition that is used for the treatment of gastritis, described adjuvant are one or more of dextrin, lactose, starch, sucrose, glucose, microcrystalline Cellulose, mannose, methylcellulose, hydroxypropyl cellulose, carboxymethyl cellulose and stevioside.
The above-mentioned preparation method that is used for the treatment of the Chinese medicine composition of gastritis, it comprises the steps: to get the Rhizoma Pinelliae, the Radix Aucklandiae, Herba Lysimachiae, Fructus Forsythiae, Fructus Amomi Rotundus, Rhizoma Corydalis, Fructus Toosendan, Herba Hyperici Japonici, Rhizoma Coptidis, Poria, Radix Bupleuri, the Rhizoma Atractylodis Macrocephalae, Fructus Aurantii, Cortex Magnoliae Officinalis, Fructus Akebiae, Semen Arecae, Radix Angelicae Sinensis, Endothelium Corneum Gigeriae Galli, Concha Arcae, licorice medicinal materials merges, decoct with water twice, collecting decoction, relative density is the extractum of 1.15-1.20 when being evaporated to 65 ℃, adding ethanol makes the percent by volume that contains the alcohol amount reach 75-85%, stir, leave standstill, filter, relative density was 1.25-1.30 when filtrate decompression was concentrated into 65 ℃, and Recycled ethanol, get concentrated solution, concentrated solution is added water and adjuvant is mixed with oral liquid, or with the concentrated solution spray drying, add adjuvant and make capsule, tablet, granule.
The above-mentioned preparation method that is used for the treatment of the Chinese medicine composition of gastritis, in the step, decocting condition is: the 8-12 that adds for the first time water and be medical material weight doubly measures, and decocts 1-2h, and the 6-10 that adds water for the second time and be medical material weight doubly measures, and decocts 1-2h.
The above-mentioned preparation method that is used for the treatment of the Chinese medicine composition of gastritis, in the step, the spray drying condition is: inlet temperature is 100-120 ℃, leaving air temp is 80-90 ℃, temperature of charge is 70-90 ℃, and atomizing pressure is the 0.2-0.4 MPa, and spray velocity is 5-10ml/s.
The above-mentioned application of Chinese medicine composition in the medicine of preparation treatment gastritis that is used for the treatment of gastritis.
Beneficial effect:
1, from theory of Chinese medical science, the Rhizoma Pinelliae, the Radix Aucklandiae, Herba Lysimachiae, Fructus Forsythiae, Fructus Amomi Rotundus, Rhizoma Corydalis, Fructus Toosendan, Herba Hyperici Japonici removing dampness by means of aromatics among the we, be monarch drug, the stomach invigorating of regulating the flow of vital energy of Rhizoma Coptidis, Poria, Radix Bupleuri, the Rhizoma Atractylodis Macrocephalae, Fructus Aurantii, Cortex Magnoliae Officinalis, Fructus Akebiae, Semen Arecae is ministerial drug, and Radix Angelicae Sinensis, Endothelium Corneum Gigeriae Galli, Concha Arcae, Radix Glycyrrhizae are adjuvant, all medicines are harmonious, play altogether removing dampness by means of aromatics, the digestion promoting function of regulating the flow of vital energy is used for the treatment of gastritis.
2, Formulation of the present invention is reasonable, and compatibility is rigorous, through long-term clinical verification, determined curative effect.
3, the present invention consists of Chinese crude drug, and Herba Hyperici Japonici is the herb of Garcinia maingayii Herba Hyperici Japonici, and Fructus Akebiae is the fruit of BENTONG section plant Caulis Akebiae, threeleaf akebia, white BENTONG, and all the other are the pharmacopeia kind, have no side effect low price.
The specific embodiment
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention only limits to following example, all technology that realizes based on foregoing of the present invention all belong to scope of the present invention.
1, Preparation Example
Embodiment 1: get Rhizoma Pinelliae 5g, Radix Aucklandiae 20g, Herba Lysimachiae 15g, Fructus Forsythiae 25g, Fructus Amomi Rotundus 10g, Rhizoma Corydalis 20g, Fructus Toosendan 10g, Herba Hyperici Japonici 20g, Rhizoma Coptidis 15g, Poria 25g, Radix Bupleuri 15g, Rhizoma Atractylodis Macrocephalae 5g, Fructus Aurantii 25g, Cortex Magnoliae Officinalis 10g, Fructus Akebiae 25g, Semen Arecae 10g, Radix Angelicae Sinensis 25g, Endothelium Corneum Gigeriae Galli 10g, Concha Arcae 25g, Radix Glycyrrhizae 15g medical material merges, decoct with water twice, add for the first time 8 times of amounts that water is medical material weight, decoct 1h, add for the second time 6 times of amounts that water is medical material weight, decoct 1h, collecting decoction, 0.07MPa, relative density is 1.10 when being evaporated to 65 ℃ under 60-70 ℃, adding 95% (v/v) ethanol makes the alcohol amount of containing reach 85% (v/v), stir, left standstill 24 hours, decompression filtrate recycling ethanol is also concentrated, and filtrate is at 0.07MPa, relative density was 1.30 when concentrating under reduced pressure became to 65 ℃ under 65 ℃ of conditions, and (condition is that inlet temperature is 120 ℃ to spray drying, leaving air temp is 100 ℃, temperature of charge is 90 ℃, and atomizing pressure is 0.4 MPa, and spray velocity is 10ml/s.), adding starch, mix homogeneously with the moistening of an amount of 80% (v/v) ethanol, soft material processed, is crossed 30 mesh sieves and is granulated, and in 70 ~ 80 ℃ of dryings, with 60 mesh sieve granulate, tabletting, sugar coating, packing, outer package, censorship is qualified, gets tablet.
Embodiment 2: get Rhizoma Pinelliae 10g, Radix Aucklandiae 15g, Herba Lysimachiae 20g, Fructus Forsythiae 20g, Fructus Amomi Rotundus 15g, Rhizoma Corydalis 15g, Fructus Toosendan 15g, Herba Hyperici Japonici 15g, Rhizoma Coptidis 20g, Poria 20g, Radix Bupleuri 20g, Rhizoma Atractylodis Macrocephalae 8g, Fructus Aurantii 20g, Cortex Magnoliae Officinalis 15g, Fructus Akebiae 20g, Semen Arecae 15g, Radix Angelicae Sinensis 20g, Endothelium Corneum Gigeriae Galli 15g, Concha Arcae 20g, Radix Glycyrrhizae 20g medical material merges, decoct with water twice, add for the first time 10 times of amounts that water is medical material weight, decoct 1.5h, add for the second time 8 times of amounts that water is medical material weight, decoct 1.5h, collecting decoction, 0.07MPa, relative density is 1.15 when being evaporated to 65 ℃ under 60-70 ℃, adding 95% (v/v) ethanol makes the alcohol amount of containing reach 75% (v/v), stir, left standstill 24 hours, decompression filtrate recycling ethanol is also concentrated, and filtrate is at 0.07MPa, relative density was 1.25 when concentrating under reduced pressure became to 65 ℃ under 65 ℃ of conditions, and (condition is that inlet temperature is 100 ℃ to spray drying, leaving air temp is 80 ℃, temperature of charge is 80 ℃, and atomizing pressure is 0.2 MPa, and spray velocity is 5ml/s.), adding dextrin etc., dry granulation is crossed 60 mesh sieves, and No. 1 capsule of packing into gets final product to get capsule.
Embodiment 3: get Rhizoma Pinelliae 15g, Radix Aucklandiae 10g, Herba Lysimachiae 25g, Fructus Forsythiae 15g, Fructus Amomi Rotundus 20g, Rhizoma Corydalis 10g, Fructus Toosendan 20g, Herba Hyperici Japonici 10g, Rhizoma Coptidis 25g, Poria 15g, Radix Bupleuri 25g, Rhizoma Atractylodis Macrocephalae 5g, Fructus Aurantii 25g, Cortex Magnoliae Officinalis 10g, Fructus Akebiae 25g, Semen Arecae 10g, Radix Angelicae Sinensis 25g, Endothelium Corneum Gigeriae Galli 10g, Concha Arcae 25g, Radix Glycyrrhizae 15g medical material merges, decoct with water twice, add for the first time 12 times of amounts that water is medical material weight, decoct 2h, add for the second time 10 times of amounts that water is medical material weight, decoct 2h, collecting decoction, 0.07MPa, relative density is 1.15 when being evaporated to 65 ℃ under 60-70 ℃, adding 95% (v/v) ethanol makes the alcohol amount of containing reach 75% (v/v), stir, left standstill 24 hours, decompression filtrate recycling ethanol is also concentrated, and filtrate is at 0.07MPa, relative density was 1.25 when concentrating under reduced pressure became to 65 ℃ under 65 ℃ of conditions, and (condition is that inlet temperature is 110 ℃ to spray drying, leaving air temp is 85 ℃, temperature of charge is 85 ℃, and atomizing pressure is 0.3 MPa, and spray velocity is 7.5ml/s.), add above-mentioned Benexate Hydrochloride, pulverize, add again suitable lactose, with the moistening of an amount of 80% (v/v) ethanol, soft material processed, cross 14 mesh sieves and granulate, 50-80 ℃ of drying, 60 order granulate get granule.
Embodiment 4: get Rhizoma Pinelliae 10g, Radix Aucklandiae 15g, Herba Lysimachiae 20g, Fructus Forsythiae 20g, Fructus Amomi Rotundus 15g, Rhizoma Corydalis 15g, Fructus Toosendan 15g, Herba Hyperici Japonici 15g, Rhizoma Coptidis 20g, Poria 20g, Radix Bupleuri 20g, Rhizoma Atractylodis Macrocephalae 8g, Fructus Aurantii 20g, Cortex Magnoliae Officinalis 15g, Fructus Akebiae 20g, Semen Arecae 15g, Radix Angelicae Sinensis 20g, Endothelium Corneum Gigeriae Galli 15g, Concha Arcae 20g, Radix Glycyrrhizae 20g medical material merges, decoct with water twice, add for the first time 10 times of amounts that water is medical material weight, decoct 1.5h, add for the second time 8 times of amounts that water is medical material weight, decoct 1.5h, collecting decoction, 0.07MPa, relative density is 1.15 when being evaporated to 65 ℃ under 60-70 ℃, adding 95% (v/v) ethanol makes the alcohol amount of containing reach 75% (v/v), stir, left standstill 24 hours, decompression filtrate recycling ethanol is also concentrated, filtrate is at 0.07MPa, relative density was 1.25 when concentrating under reduced pressure became to 65 ℃ under 65 ℃ of conditions, add water and sucrose, be prepared into oral liquid.
2. on the pharmacodynamic study that affects of laboratory animal
Experimental agents: by the preparation of the preparation method of above-mentioned oral liquid embodiment: i.e. Rhizoma Pinelliae 10g, Radix Aucklandiae 15g, Herba Lysimachiae 20g, Fructus Forsythiae 20g, Fructus Amomi Rotundus 15g, Rhizoma Corydalis 15g, Fructus Toosendan 15g, Herba Hyperici Japonici 15g, Rhizoma Coptidis 20g, Poria 20g, Radix Bupleuri 20g, Rhizoma Atractylodis Macrocephalae 8g, Fructus Aurantii 20g, Cortex Magnoliae Officinalis 15g, Fructus Akebiae 20g, Semen Arecae 15g, Radix Angelicae Sinensis 20g, Endothelium Corneum Gigeriae Galli 15g, Concha Arcae 20g, Radix Glycyrrhizae 20g medical material merges, decoct with water twice, add for the first time 10 times of amounts that water is medical material weight, decoct 1.5h, add for the second time 8 times of amounts that water is medical material weight, decoct 1.5h, collecting decoction, 0.07MPa, relative density is 1.15 when being evaporated to 65 ℃ under 60-70 ℃, adding 95% (v/v) ethanol makes the alcohol amount of containing reach 75% (v/v), stir, left standstill 24 hours, decompression filtrate recycling ethanol is also concentrated, filtrate is at 0.07MPa, relative density was 1.25 when concentrating under reduced pressure became to 65 ℃ under 65 ℃ of conditions, add water and sucrose, be prepared into oral liquid, get 20 of oral liquid finished products.Specification: 10ml/ props up (being equivalent to contain crude drug 16g)
Dosage: according to " the dose,equivalent ratio table of converting by the surface between humans and animals ", every day, 70 kilograms of people's consumption was 48g, every day, the consumption of every 200g rat was 48*0.018=0.86g, be 16g because every oral liquid 10ml contains the crude drug amount, the consumption that is every rat is 0.54ml, therefore determine low dose of every gavage 0.5ml oral liquid, middle dosage and high dose be gavage 1ml and 2ml respectively, the oral liquid of every 200g rat oral gavage contained the crude drug amount and was respectively 0.8g every day, 1.6g, 3.2g, then by rat body weight, low dosage, middle dosage and high dose are respectively 4g crude drug amount/kg, 8g crude drug amount/kg and 16g crude drug amount/kg.
60 of laboratory animal: SD cleaning level rats, male, body weight 180～210g, Shanghai Si Laike Experimental Animal Center provides.
Experiment reagent: vitacoenzyme tablet, the Hebei pharmaceutcal corporation, Ltd of being surrounded by sea, lot number 20110611; Sodium salicylate, Jiangsu be magnificent fine chemicals company limited forever, lot number 090709; 95% medical alcohol, Nanjing rather try the chemical reagent company limited, lot number 20071128; Ammonia, the Long Huagongshijichang of Chengdu section, lot number 20080622; Motilin, gastrin radioimmunological kit, Beijing Fu Rui bio-engineering corporation.
Experimentation: at random 60 rats are divided into 6 groups, be respectively: dosage group, the heavy dose of group of the present invention in blank group, model group, vitacoenzyme group, small dose group of the present invention, the present invention, every group of l0 only, modeling is except the normal raising of blank group, other 5 groups are adopted 2% sodium salicylate and 30% ethanol mixed solution, water 1h, 10mL/kg are prohibited in fasting before and after the set time every day gavage, gavage; Rat is freely drunk 0.05% ammonia; Cooperate the irregular diet method, every feed 2d, fasting 1d.Randomly draw two before modeling finishes and do the gastric mucosa pathological histology inspection, confirm the atrophy of gastric mucosa body of gland to occur, intestinal and atypical hyperplasia etc. stop the modeling medicine, enter treatment stage.Modeling amounted to for 17 weeks.Treatment amounted to for 4 weeks.After the end, rat fasting 24h, 1.5% pentobarbital intraperitoneal injection of anesthesia is cut off the approximately otch of 2.5cm along hunter's line under xiphoid-process, carefully mention stomach, in pylorus and the stitching thread ligation of duodenum joint portion, avoids blood vessel.Send back in the cage behind the sewing-up cut.Behind the 3h, the ligation cardia is cut off respectively esophagus lower end and duodenum near-end again, extract full stomach, flush away surface blood stains blot with filter paper, put in the culture dish and cut off gastral cavity along greater gastric curvature, collect gastric juice in centrifuge tube, with the centrifugal 20min of 3000rpm, draw supernatant, carry out gastric analysis, the special capillary tube method of wheat is surveyed pepsin, and the result is as follows:
Table 1 the present invention is on pepsin impact research (X ± SD)
Annotate: compare * P＜0.05 with model group; * P＜0.01
Experiment conclusion: the present invention can improve pepsin activity in the gastritis rat model gastric juice, demonstrates gastritis is had certain therapeutical effect.
Claims (8)
1. Chinese medicine composition that is used for the treatment of gastritis, it is characterized in that, it is prepared by the raw material of following parts by weight: Rhizoma Pinelliae 5-15 part, Radix Aucklandiae 10-20 part, Herba Lysimachiae 15-25 part, Fructus Forsythiae 15-25 part, Fructus Amomi Rotundus 10-20 part, Rhizoma Corydalis 10-20 part, Fructus Toosendan 10-20 part, Herba Hyperici Japonici 10-20 part, Rhizoma Coptidis 15-25 part, Poria 15-25 part, Radix Bupleuri 15-25 part, Rhizoma Atractylodis Macrocephalae 5-10 part, Fructus Aurantii 15-25 part, Cortex Magnoliae Officinalis 10-20 part, Fructus Akebiae 15-25 part, Semen Arecae 10-20 part, Radix Angelicae Sinensis 15-25 part, Endothelium Corneum Gigeriae Galli 10-20 part, Concha Arcae 15-25 part, Radix Glycyrrhizae 15-25 part.
2. the Chinese medicine composition that is used for the treatment of gastritis according to claim 1, it is characterized in that, it is prepared by the raw material of following parts by weight: 10 parts of the Rhizoma Pinelliaes, 15 parts of the Radix Aucklandiae, 20 parts of Herba Lysimachiaes, 20 parts of Fructus Forsythiaes, 15 parts of Fructus Amomi Rotunduss, 15 parts of Rhizoma Corydalis, 15 parts of Fructus Toosendans, 15 parts of Herba Hyperici Japonici, 20 parts of Rhizoma Coptidis, 20 parts in Poria, 20 parts of Radix Bupleuri, 8 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Fructus Aurantiis, 15 parts of Cortex Magnoliae Officinalis, 20 parts of Fructus Akebiaes, 15 parts of Semen Arecaes, 20 parts of Radix Angelicae Sinensis, 15 parts of Endothelium Corneum Gigeriae Galli, 20 parts of Concha Arcaes, 20 parts in Radix Glycyrrhizae.
3. the Chinese medicine composition that is used for the treatment of gastritis according to claim 1 and 2 is characterized in that, described raw material adds adjuvant and makes oral liquid, tablet, capsule or granule after extracting.
4. the Chinese medicine composition that is used for the treatment of gastritis according to claim 3, it is characterized in that, described adjuvant is one or more of dextrin, lactose, starch, sucrose, glucose, microcrystalline Cellulose, mannose, methylcellulose, hydroxypropyl cellulose, carboxymethyl cellulose and stevioside.
5. claim 1 or the 2 described preparation methoies that are used for the treatment of the Chinese medicine composition of gastritis, it is characterized in that, it comprises the steps: to get the Rhizoma Pinelliae, the Radix Aucklandiae, Herba Lysimachiae, Fructus Forsythiae, Fructus Amomi Rotundus, Rhizoma Corydalis, Fructus Toosendan, Herba Hyperici Japonici, Rhizoma Coptidis, Poria, Radix Bupleuri, the Rhizoma Atractylodis Macrocephalae, Fructus Aurantii, Cortex Magnoliae Officinalis, Fructus Akebiae, Semen Arecae, Radix Angelicae Sinensis, Endothelium Corneum Gigeriae Galli, Concha Arcae, licorice medicinal materials merges, decoct with water twice, collecting decoction, relative density is the extractum of 1.15-1.20 when being evaporated to 65 ℃, adding ethanol makes the percent by volume that contains the alcohol amount reach 75-85%, stir, leave standstill, filter, relative density was 1.25-1.30 when filtrate decompression was concentrated into 65 ℃, and Recycled ethanol, get concentrated solution, concentrated solution is added water and adjuvant is mixed with oral liquid, or with the concentrated solution spray drying, add adjuvant and make capsule, tablet, granule.
6. the preparation method that is used for the treatment of the Chinese medicine composition of gastritis according to claim 5 is characterized in that, in the step, decocting condition is: the 8-12 that adds for the first time water and be medical material weight doubly measures, decoct 1-2h, the 6-10 that adds water for the second time and be medical material weight doubly measures, and decocts 1-2h.
7. the preparation method that is used for the treatment of the Chinese medicine composition of gastritis according to claim 5, it is characterized in that, in the step, the spray drying condition is: inlet temperature is 100-120 ℃, leaving air temp is 80-90 ℃, temperature of charge is 70-90 ℃, and atomizing pressure is the 0.2-0.4 MPa, and spray velocity is 5-10ml/s.
8. claim 1 or the 2 described application of Chinese medicine composition in the medicine of preparation treatment gastritis that are used for the treatment of gastritis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210524123.6A CN102940845B (en) | 2012-12-08 | 2012-12-08 | Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210524123.6A CN102940845B (en) | 2012-12-08 | 2012-12-08 | Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102940845A true CN102940845A (en) | 2013-02-27 |
| CN102940845B CN102940845B (en) | 2014-08-20 |
Family
ID=47723905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210524123.6A Expired - Fee Related CN102940845B (en) | 2012-12-08 | 2012-12-08 | Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102940845B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104306544A (en) * | 2014-11-09 | 2015-01-28 | 朱海燕 | Traditional Chinese medicine composition for treating chronic atrophic gastritis as well as preparation method and application thereof |
| CN106138987A (en) * | 2015-04-13 | 2016-11-23 | 周海腾 | A kind of Chinese medicine oral liquid treating gastritis |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1110592A (en) * | 1994-10-21 | 1995-10-25 | 孟灵源 | Pill for treating hepatogastric vital energy stagnation type chronic superficial, atrophic gastritis |
| CN101062212A (en) * | 2007-06-07 | 2007-10-31 | 巩振宏 | Chinese medicinal herb composition for treating gastritis |
| CN101647940A (en) * | 2009-08-22 | 2010-02-17 | 冯少军 | Traditional Chinese medicine for treating gastritis and preparation method thereof |
| CN101721574A (en) * | 2008-11-03 | 2010-06-09 | 任风辉 | Traditional Chinese medicine formula for treating gastritis |
| CN101972443A (en) * | 2010-10-18 | 2011-02-16 | 朱新华 | Chinese medicinal formula for treating chronic gastritis |
| CN102038894A (en) * | 2009-10-15 | 2011-05-04 | 张红旗 | Prescription for curing bile regurgitational gastritis |
| CN102178887A (en) * | 2011-05-16 | 2011-09-14 | 汤炳显 | Traditional Chinese medicine for treating gastropathy |
| CN102274466A (en) * | 2011-08-15 | 2011-12-14 | 荣成市商贸城卫生所 | Chinese medicinal composition for treating gastritis |
| CN102319336A (en) * | 2011-09-21 | 2012-01-18 | 万燕丽 | Traditional Chinese medicine for treating gastritis |
| CN102552851A (en) * | 2012-02-03 | 2012-07-11 | 河南中医学院 | Traditional Chinese medicine for treating chronic gastrointestinal diseases |
-
2012
- 2012-12-08 CN CN201210524123.6A patent/CN102940845B/en not_active Expired - Fee Related
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1110592A (en) * | 1994-10-21 | 1995-10-25 | 孟灵源 | Pill for treating hepatogastric vital energy stagnation type chronic superficial, atrophic gastritis |
| CN101062212A (en) * | 2007-06-07 | 2007-10-31 | 巩振宏 | Chinese medicinal herb composition for treating gastritis |
| CN101721574A (en) * | 2008-11-03 | 2010-06-09 | 任风辉 | Traditional Chinese medicine formula for treating gastritis |
| CN101647940A (en) * | 2009-08-22 | 2010-02-17 | 冯少军 | Traditional Chinese medicine for treating gastritis and preparation method thereof |
| CN102038894A (en) * | 2009-10-15 | 2011-05-04 | 张红旗 | Prescription for curing bile regurgitational gastritis |
| CN101972443A (en) * | 2010-10-18 | 2011-02-16 | 朱新华 | Chinese medicinal formula for treating chronic gastritis |
| CN102178887A (en) * | 2011-05-16 | 2011-09-14 | 汤炳显 | Traditional Chinese medicine for treating gastropathy |
| CN102274466A (en) * | 2011-08-15 | 2011-12-14 | 荣成市商贸城卫生所 | Chinese medicinal composition for treating gastritis |
| CN102319336A (en) * | 2011-09-21 | 2012-01-18 | 万燕丽 | Traditional Chinese medicine for treating gastritis |
| CN102552851A (en) * | 2012-02-03 | 2012-07-11 | 河南中医学院 | Traditional Chinese medicine for treating chronic gastrointestinal diseases |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104306544A (en) * | 2014-11-09 | 2015-01-28 | 朱海燕 | Traditional Chinese medicine composition for treating chronic atrophic gastritis as well as preparation method and application thereof |
| CN106138987A (en) * | 2015-04-13 | 2016-11-23 | 周海腾 | A kind of Chinese medicine oral liquid treating gastritis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102940845B (en) | 2014-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102940846B (en) | Traditional Chinese medicine composition for treating atrophic gastritis as welln as preparation method and application of composition | |
| CN102895432A (en) | Prescription and preparation method of rejoicing powder having new dosage form | |
| CN102258680B (en) | Chinese medicinal composition for reliving physical fatigue and preparation method and use thereof | |
| CN102935187A (en) | Traditional Chinese medicinal composition for treating chronic atrophic gastritis, and preparation method and application thereof | |
| CN102940845B (en) | Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition | |
| CN104069344A (en) | Traditional Chinese medicine composition for treating cancer and preparation and preparation method thereof | |
| CN104001004A (en) | Traditional Chinese medicine composition for curing fractures and osteoporosis and preparation method and application thereof | |
| CN103845633B (en) | It is a kind of to treat Chinese medicine composition of canker sore and preparation method thereof | |
| CN103301279A (en) | Traditional Chinese medicine for preventing and treating bovine forestomach disease and preparation method of compound oral tablet thereof | |
| CN102204978A (en) | Medicinal composition for treating cancer pain and preparation thereof | |
| CN102258583B (en) | Traditional Chinese medicine preparation for treating chronic and nonspecific ulcerative colitis and preparation method thereof | |
| CN104000883B (en) | A kind of tablet for the treatment of gastritis and its preparation method and application | |
| CN101194945A (en) | Tablet for treating headache and method for preparing the same | |
| CN106563076B (en) | Medicine for treating stomach disease and its preparing method | |
| CN104435079A (en) | Traditional Chinese medicinal composition for treating gout | |
| CN111388584A (en) | Composition for treating impotence and preparation method thereof | |
| CN102772645B (en) | Traditional Chinese medicine for treating cold and preparation method thereof | |
| CN108079089B (en) | Traditional Chinese medicine composition for treating diabetic nephropathy and preparation method thereof | |
| CN102258713A (en) | Chinese medicinal composition for preventing and treating metabolic diseases | |
| CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
| CN105396107A (en) | Traditional Chinese medicine composition for curing gastroenteritis | |
| CN104306528A (en) | Traditional Chinese medicine composition for curing gastritis and preparation method thereof as well as application thereof | |
| CN101264208A (en) | Medicinal composition for treating stomach and intestine dysfunction and preparation thereof | |
| CN104958430A (en) | Traditional Chinese medicinal composition for treating chronic trachitis and preparation method thereof | |
| CN104800805A (en) | Medicine for treating frequent micturition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANG FENGHUA Free format text: FORMER OWNER: NANJING ZHENGKUAN PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD. Effective date: 20140714 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Fenghua Inventor before: The inventor has waived the right to be mentioned |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 211224 NANJING, JIANGSU PROVINCE TO: 266000 QINGDAO, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: REQUEST NOT TO RELEASE THE NAME TO: ZHANG FENGHUA |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140714 Address after: Shinan District 266000 Shandong city of Qingdao province Ningxia road 293, building 2, unit 1, 203 households Applicant after: Zhang Fenghua Address before: 211224 No. 1 Industrial Park, Jing Qiao Town, Lishui County, Jiangsu, Nanjing Applicant before: Nanjing Zhengkuan Pharmaceutical Science and Technology Co., Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140820 Termination date: 20151208 |
|
| EXPY | Termination of patent right or utility model |